I'GI1-synthase, prostaglandin 11-synthase methacin administration from 98 5 12 mL*min-'*I00 g-' to 50 f 3, 56 f 7, and 70 f 11 mL*min-'-100 g-' at 10, 60, and 120 min, respectively. The total CBF returned to baseline levels at 240 min (101 f 16 mL-'emin-'-100 g-').
After indomethacin administration, the CRlR02 decreased Prostanoids appear to contribute to regulation of the cerebral significantly from the baseline level of 3.57 0.52 mL 02/ vascular tone in human beings and some animals, particularly 100 g-'emin-' to 2.50 f 0.39, 2.69 f 0.52, and 2.41 2 during the perinatal period. lndomethacin decreases CBF and 0.31 mL 02/100 g-'amin-' a t 10,60, and 120 min, respec-responses to hypercapnia in beagles (I), piglets (2) . rats (3) , and baboons (4) but does not decrease CBF in cats (5, 6) or rabbits t i v e l~' The Ch1R02 returned to 240 min (3'09 (7, 8) . Indomethacin is a potent reversible PGH-synthase inhib-0.46 mL 02/100 g-'*min-'). In the first group piglets, itor. In indomethacin decreases CBF at rest but more we maximum CBF responses between Inin markedly during pathologic conditions such as hypcrcapnia (9), of indomethacin administration and return of CBF to base-asphyxia (2), ischemia seizures ( ), and hypotension line values within 4 h. Therefore, in another group of piglets ~h~~~ decreases in CBF occur concomitantly with decreases in (n = lo) we determined the effect a CSF dilator PG levels (2, 10) . Indomethacin is highly lipidindomethacin On CBF. The first CBF measure-soluble but also is highly protein-bound (>90%) (13) . Even so, ments were made, and then indomethacin (5 m d k g i.v.) indomethacin can be found in the brain within 30 min of was given. The CBF measurements were repeated at 30 systemic administration (13, 14) . In premature babies, indomin. Four hours later, a second baseline CBF determination methacin has been used in the last decade for the pharmacologic was made* and a dose indOmethacin (5 mfdkg closure of the FDA (15) (16) (17) . and more recently it has been i.v.) was administered. Thirty minutes after the second suggested for use in preventing or decreasing the severity of dose of indomethacin, CBF was measured again. Total periventricu~ar-intraventricular hemorrhage (18, 19) .
CBF decreased significantly (P < 0.05) 30 min after the No information exists with regard to the duration of the effects first dose of h d~m e t h a c i n (91 f 10 to 52 f 5 of indomethacin on cerebral vascular tone in conscious animals. mL*min-'*100 g-'). BY 4 h, total and regional CBF re-In a preliminary study in anesthetized piglets, Lozen cl al. (20) Received June 1, 1993; accepted December 10, 1993. have reported that cerebrovascular reactivity to hypercapnia also the response to hypercapnia, with a concomitant decrease POURCY R( in cortical periarachnoid CSF dilator PG levels; these cffects lasted for only 2 h.
Therefore, we planned a study to investigate the effect of indomethacin on cerebral hemodynamics of unanesthetized piglets. We measured the duration of the effect of indomethacin ( 5 mg/kg i.v.) on CBF (microsphere technique) and CMROz over a 4-h period. Furthermore, we examined the CBF response to a repeated dose of indomethacin (5 mg/kg i.v.) given 4 h after the first dose.
MATERIALS A N D METHODS
The surgical and experimental procedures used were reviewed and approved by the Animal Care and Use Committee of the University of Tennessee, Memphis.
Eighteen newborn pigs 3-5 d old (0.93 to 1.9 kg) were instrumented 24 h before the experiment. Eight piglets were used for the indomethacin/time course protocol and 10 piglets for the indomethacin/repeated dose protocol. The surgery was performed under aseptic conditions. Piglets were anesthetized with a mixture of halothane, nitrous oxide, and 0 2 for the placement of the catheters. Polyurethane catheters were placed in the descending aorta (via an umbilical artery) for blood sampling and reference withdrawal of microspheres and in the left ventricle via the right carotid artery for microsphere injections. In piglets. ligation of one carotid artery has no detcctable effect on CBF (22) .
After surgery, the piglets were given benzathine penicillin and aentamicin and laced in a room with a controlled environmenial temperature.'~he piglets were provided a continual supply of pig nursing milk substitute (Purina Milk, Inc., St. Louis, MO) and water. Experimentation was performed on the 1st postoperative day. On the morning of experimentation, sagittal sinuses of piglets that were assigned to the indomethacin/time course protocol were cannulated, with the piglets under local anesthesia. with a 22-gauge Angiocath (Berman, Arrow, Reading. PA) for collection of cerebral venous blood. The Angiocath was secured with Superglue.
During experimentation, piglets were kept warm with a n overhead lamp. The piglets were fed with pig milk every 2 h via a n orogastric feeding tube that was placed before the beginning of the experiment. The piglets were placed in a cloth sling. At approximately 30 min, the baseline radioactive microsphere determinations of CBF and cardiac output were made, and blood samples were drawn from the aorta and sagittal sinus for measurement of blood gases and pH and calculation of CMR02. Indomethacin trihydrate (5 mg/kg; gift from Merck Sharp and Dohme Research Laboratories, Rahway, NJ) was dissolved in 5 m L of saline solution, and i.v. administration was performed over a 5-min period. After the indomethacin administration, the microsphere blood flow determinations and blood sampling were repeated at 10, 60, 120, and 240 min later.
After completion of the first set of experiments and analysis of the data, the second set of experiments was started. In the first group, the maximum CBF responses occurred between 10-60 min of indomethacin administration; the CBF responses returned to normal by 4 h. Therefore, in piglets that were assigned to the indomethacin/repeated dose protocol group, microsphere blood flow measurements were made at baseline and then 30 min after indomethacin (5 mg/kg i.v.) injection. Also 4 h later. a second baseline CBF was measured and a second dose of indomethacin (5 mg/kg) administered. Thirty minutes after the second dose, the CBF measurement was repeated.
Blood chemistry and dc.tertnination of ccrc.hrul osj~ctz consumplion. Blood Rat/ioucti\v r?ricrosphrrc~ 1lc~tc~r7?1itlcrtiotl of CBF A known amount of radioactivity in 15-pm microspheres (300,000-800,000 microspheres) was injected into the left ventricle, and the injection line was flushed with 1 mL saline. Withdrawal of reference blood samples (1.03 mL/min from the descending aorta) was begun 15 s before microsphere injections and continued for 2 min. Withdrawn blood was replaced with donor piglet blood. At the end of the experiment, the piglets were anesthetized with ketamine/acepromazine (33 mg/kg intramuscularly and 3.3 mg/kg intramuscularly, respectively) and killed by an injection of KC1 into the left ventricle. The brain was then removed. The brain was subdivided into major regions (cerebrum, caudate, diencephalon/mesencephalon. pons, medulla, cerebellum, and brain stem). Samples were counted in a well-type gamma counter. The energy from each nuclide was separated by differential spectroscopy. Aliquots of the actual microsphere solutions injected were used for overlap calculations. The nuclides and energy windows used were (in keV): 840-1,240 4 h S~, 7 10-8 10 '5Nb, 480-5 10 I0'Ru, 370-440 '"Sn, 100-1 50 "Co, and 36-70 lz5I. The lungs were counted to detect extensive arteriovenous shunting of microspheres. Lung blood flow (comprising of bronchial flow and whole body arteriovenous shunt flow) averaged 2% of cardiac output, indicating that no extraordinary shunting of microspheres occurred. Cardiac output was calculated as cardiac output = (reference withdrawal rate) x (counts injected) x (counts in reference withdrawal)-'. Blood flow to each brain region at the time the microspheres were injected was calculated by the following formula: Q = C x R x CR-', where Q = organ blood flow in mL/min x 100 g, C = counts/100 g tissue, R = rate of withdrawal of the reference blood sample in mL/min, and C R = total counts in the reference arterial blood sample. We assumed cerebral venous pressure to be negligible after we measured sagittal sinus pressure in several piglets and found it to be between I and 2 m m Hg and relatively constant over time.
Strrtisticrrl (rnu1jvsis. Values are reported as means a SEM.
Comparisons among different time periods were made with analysis of variance with ri'pcated measures. A p value < 0.05 was considered significant.
RESULTS
Blood pressure and core temperature were monitored continuously throughout the experiments. All piglets started with a normal blood pressure, pH, and blood gases; these values remained normal during the experiments (Table 1) . Immediately after indomethacin administration, the blood pressure increased by 20-40 m m Hg (2.7-5.3 kPa). However, the blood pressure returned to baseline values in 3-5 min (Fig. 1) . Although statistically significant changes in blood pressure occurred over time, values remained within the normal physiologic ranges. No correlation between changes in blood pressure and the changes in CBF or C M R 0 2 was observed.
In the indomethacin/time course protocol group after indomethacin administration, regional and total CBF had decreased significantly when measured at 10 min and remained significantly rcduced for 120 min in all regions of the brain when compared with baseline values (Table 2) . By 240 min, total and regional CBF had returned to baseline levels in all regions of the brain except for the caudate nucleus, where blood flow returned to the baseline level earlier (by 120 rnin). The CMRO* decreased significantly after indomethacin administration and stayed low for 120 min. By 240 min, the CMROz was not significantly reduced when compared with baseline.
Piglets in the indomethacin/repeated dose protocol group also started with normal blood pressure, pH, and blood gases; values stayed normal during the course of the experiments (Table 3) . Regional and total CBF decreased significantly 30 rnin after the administration of the first dose of indomethacin (Table 4 ). The CBF returned to the baseline level (baseline I ) at 4 h (baseline 2): therefore no significant differences in CBF were observcd betwcen baseline 1 and baseline 2. The second dose of indomethacin was given 4 h after the first dose, and CBF was measured 30 min later. After the sccond dose of indomethacin, CBF again decreased significantly whcn comparcd with baseline 2, except for the pons, where the decrease, although apparent, was not significant ( p < 0.05).
DISCUSSION
The new findings of this study are 1 ) that i.v. administration of indomethacin (5 mg/kg) to unanesthetized piglets results in decreased CBF and C M R 0 2 lasting for more than 2 h, returning to baseline values by 4 h; and 2) the same dose of indomethacin given 4 h after the first dose rcsults in a decrease in CBF similar to that evoked by the first dose.
Prostanoids appear to contribute to the regulation of the ccrcbral vascular tone during physiologic and pathologic conditions in some newborn animals (1, 2, 5, 23) and in human neonates (24, 25) . In piglets, concentrations of cortical periarachnoid CSF dilator prostanoids increase during hypercapnia (10) . hypotension (12) . and asphyxia (2) . These conditions are associated with pial arteriolar dilation and cerebral vascular hypere- mia (2, 12, 26) , responses that can be attenuated or blocked by indomethacin administration (2, 12) . Indomethacin is a potent and reversible inhibitor of PGH-synthase, and it is highly proteinbound (13, 14) . Free indomethacin is known to be highly lipophylic; thus, it crosses the intact meninges by simple diffusion (13) . Although direct measurement of the CSF indomethacin level has not been made in experimental animals, the effects of indomethacin on CSF prostanoids, pial arteriolar diameter, and CBF are confirmatory of sufficient indomethacin passage via the blood-brain barrier (2, 9, 12).
The reported plasma half-life of indomethacin during the 0-phase (elimination phase) in human babies ranges from 11-32 h (27, 28) , which is much longer than in adults (13) . However, the indomethacin half-life during the a-phase (distribution phase) is much shorter than in the P-phase. Although the reported plasma half-life of indomethacin in newborn babies is long, the effects on the cerebral vasculature are seemingly short-lived. Thalji ct al. (29) reported that premature babies who required 0.3 mg indomethacin/kg i.v. for PDA closure had a n indomethacin halflife of 80 min during the a-phase and 15 h during the @-phase. It seems that the effect of indomethacin on the cerebral vasculature occurs during the a-phase of distribution, a short period with a relatively high plasma level of indomethacin. A study by Van Bel et a/. (24) in preterm infants showcd that indomethacin at 0. I mg/kg i.v. for closure of the PDA induced a drop in CBFV that lasted for 2 h; by 3 h, however, the CBFV was back to normal. Pryds et ul. (30) measured the CBF by the i.v. 133-xenon technique in six newborn babies who required indomethacin at 0.2 mg/kg for closure ofthe PDA; they observed a decrease in CBF that lasted for at least 1 h. Similar responses have been reported in anesthetized animals (20,2 1). Lozen ct 01. (20) reported in a preliminary study that the inhibition by indomethacin of the cerebral hyperemic response to hypercapnia was lost by 2 h in anesthetized piglets given 5 mg indomethacin/ kg. Lemer rt ul. (21) observed that in anesthetized piglets i.v. indomethacin (5 mg/kg i.v.) blocked the pial arteriolar dilation response to topical application of arachidonic acid and also the response to hypercapnia with a concomitant decrease in cortical periarachnoid CSF dilator P C levels. This blocking effect of indomethacin on the pial arteriolar dilation responses to arachidonic acid and hypercapnia was lost by 3 h. In our unanesthetized piglets, we also observed a significant drop in CBF (49%) when measured at 10 min after 5 mg indomethacinlkg (i.v.). The CBF remained decreased for at least 2 h but returned to baseline values by 4 h. Therefore, although our piglets were not anesthetized, the effects of indomethacin on CBF in our experiment were similar to those of others (20, 21) .
We observed a significant drop in the CMRO? level after indomethacin administration that followed a pattern similar to that of the CBFchanges. However, the percent change in CMRO? was less than the percent change in CBF. The percent changes from baseline in C M R 0 2 at 10 and 60 min were 30% and 25%, respectively, whereas the percent changes from baseline in CBF were 49% and 43% in the same periods. Therefore, the decrease in CBF did not appear to be the result of the decrease in CMRO? rather than the result of the effect of indomethacin on cerebrovascular tone. A study by Hohimcr rl 01. (31) on fetal lambs showcd that indomethacin did not affect cerebral 0. consumption because the fall in CBF was compensated by a widening of the arteriovenous O2 content difference. Therefore, decreased CBF caused by indomethacin does not result from a decrease in cerebral metabolism. Lemer cf ul. (23) found a significant fall in CMROz 40 min after hemorrhagic hypotension in unanesthetized piglets that received 0.2 mg indomethacin/kg i.v.. Pick-ard and MacKenzie (32) found that in phcncyclidine-anesthetized baboons, 10 mg indomethacinlkg i.v. resulted in a 38% drop in CBF with no significant effect on CMRO?. In one study, Dahlgren et al. (3) showed that 10 mg indomethacin/kg in paralyzed and anesthetized rats decreased the CBF by 50% when measured at 30 min, but no statistically significant change was documented in CMRO2. When Dahlgren and Siesjo (33) added more animals to the study population, they found that indomethacin caused a significant reduction in CMRO?.
The effect of indomethacin on cerebral 0: delivery in human babies was examincd by Edwards ct (11. (25) . They studied 13 preterm infants who required indomethacin at 0.1-0.2 mg/kg for closure of the PDA and found a significant drop in cerebral 0: delivery as measured by near infrared spectroscopy. Although they did not measure CMRO?, they recommended that babies who require indomethacin administration should be optimally oxygenated before treatment.
We also examincd whether a repeated dose of indomethacin would result in a decrease in CBF as the first dose did. A study by Cowan (34) on three newborn babies who received indomethacin at 0.2 mg/kg for PDA closure showed a transient decrease in CBFV that was measured by pulsed Doppler ultrasonography. However, when the measurement was repeated on one baby 12 h later and immediately after the second dose, no change in CBF was observed. Also, Laudignon cl ul. (35) studied 13 preterm infants who received repeated doses of indomethacin (0.2 mg/ kg) for PDA closure and found no significant change in CBFV after repeated doses. The lack of a CBF response to repeated doses of indomethacin was explained by Laudignon ct ul. (35) as the following: cerebrovascular contraction was observed after the first dose of indomethacin, which persisted because of the prolonged half-life, thus preventing contraction from being observed with a repeated dose. However, a recent study by Bottu a/. (36) on newborn babies showed decreased CBFV for up to 2 h with the first and also with a repeated dose of indomethacin. We observed a significant drop in CBF with the first dosc of indomethacin and also with the repeated dose given 4 h later. Our previous study in anesthetized piglets showed similar results (2 1).
In conclusion, indomethacin at 5 mg/kg i.v. in awake piglets results in decreases in both CBF and CMRO:. This effect lasts for 2 h, but both CBF and CMROz return to normal values by 4 h. A repeated dose of indomethacin at 5 mg/kg i.v. given 4 h later results in a drop in CBF comparable to what occurred after the first dose. On the basis of our study, the short duration of the pharmacologic effects of indomcthacin should be taken into consideration when it is used experimentally to evaluate the effects of cerebral prostanoids on cerebral hemodynamics. Its short duration of cerebrovascular effect is also important in clinical settings because indomethacin has been recently suggested for preventing or decreasing the severity of pcriventricularintraventricular hemorrhage in prcmature babies (18, 19) . In newborn babies, the dosc of indomethacin that is being used for PDA closure is small (0.2-0.3 mg/kg i.v.) when compared with much larger doses (5-10 mg/kg i.v.) used in animal studies to inhibit PGH-synthase. However, the CBF and CBFV both decreased after indomethacin administration in newborn babies and also in animal studies. The similarities in duration of CBF responses might be explained by two facts. First, newborn pigs have a blood pH that is more alkalotic than that of ncwborn babies; less free indomethacin is available in alkalotic pH. Second, although the indomethacin isgiven at a low dose in newborn babies, because o f a low plasma protein level in premature babies, less indomethacin is bound to protein: therefore, more free indomethacin is available to cross the blood-brain barrier.
Pertinent to the clinical settings are our findings of a rapid decrease in CBF and CMRO: after indomethacin administration in awake healthy piglets. Therefore, it appears appropriate to give indomethacin, whether as an initial or as a repeated dosc, only when the infant's blood pressure, arterial pH, and arterial blood gases are within the clinically accepted physiologic ranges.
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